Cargando…

Pneumonic vs Nonpneumonic Acute Exacerbations of COPD

STUDY OBJECTIVE: To describe and compare the background, clinical manifestations, disease course, and infectious etiologies of pneumonic acute exacerbations (PNAE) vs nonpneumonic acute exacerbations (NPAE) of COPD. DESIGN: A prospective, observational study. SETTING: A tertiary university medical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lieberman, David, Lieberman, Devora, Gelfer, Yevgenia, Varshavsky, Raiesa, Dvoskin, Bella, Leinonen, Maija, Friedman, Maureen G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American College of Chest Physicians. Published by Elsevier Inc. 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094389/
https://www.ncbi.nlm.nih.gov/pubmed/12377851
http://dx.doi.org/10.1378/chest.122.4.1264
_version_ 1783510460428976128
author Lieberman, David
Lieberman, Devora
Gelfer, Yevgenia
Varshavsky, Raiesa
Dvoskin, Bella
Leinonen, Maija
Friedman, Maureen G.
author_facet Lieberman, David
Lieberman, Devora
Gelfer, Yevgenia
Varshavsky, Raiesa
Dvoskin, Bella
Leinonen, Maija
Friedman, Maureen G.
author_sort Lieberman, David
collection PubMed
description STUDY OBJECTIVE: To describe and compare the background, clinical manifestations, disease course, and infectious etiologies of pneumonic acute exacerbations (PNAE) vs nonpneumonic acute exacerbations (NPAE) of COPD. DESIGN: A prospective, observational study. SETTING: A tertiary university medical center in southern Israel. PATIENTS: Twenty-three hospitalizations for PNAE and 217 hospitalizations for NPAE were included in the study. Paired sera were obtained for each of the hospitalizations and were tested serologically for 12 pathogens. Only a significant change in antibody titers or levels was considered diagnostic. RESULTS: No significant differences were found between the two groups for any of the parameters related to COPD or comorbidity. The clinical type of the exacerbation was not significantly different between the groups. Compared to NPAE, patients with PNAE had lower Po(2) values at hospital admission (p = 0.004) but higher rates of abrupt onset (p = 0.005), ICU admissions (p = 0.006), invasive mechanical ventilation (p = 0.01), mortality (p = 0.007), and longer hospital stay (p = 0.001). In 22 PNAE hospitalizations (96%) and in 153 NPAE hospitalizations (71%), at least one infectious etiology was identified (p = 0.001). Mixed infection was found in 13 patients with PNAE (59%) and in 59 patients with NPAE (39%; not significant [NS]). Viral etiology was identified in 18 patients with PNAE (78%) compared with 99 patients with NPAE (46%; p = 0.003). Pneumococcal etiology was found in 10 patients with PNAE (43%) and in 38 patients with NPAE (18%; p = 0.006). An atypical etiology was identified in 8 patients with PNAE (35%) and 64 patients with NPAE (30%; NS). CONCLUSIONS: Community-acquired pneumonia is common among patients hospitalized for an acute exacerbation of COPD and is generally manifested by more severe clinical and laboratory parameters. In PNAE, compared to NPAE, viral and pneumococcal etiologies are more common, but the rate of atypical pathogens is similar. The therapeutic significance of these findings should be investigated further.
format Online
Article
Text
id pubmed-7094389
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher The American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-70943892020-03-25 Pneumonic vs Nonpneumonic Acute Exacerbations of COPD Lieberman, David Lieberman, Devora Gelfer, Yevgenia Varshavsky, Raiesa Dvoskin, Bella Leinonen, Maija Friedman, Maureen G. Chest Article STUDY OBJECTIVE: To describe and compare the background, clinical manifestations, disease course, and infectious etiologies of pneumonic acute exacerbations (PNAE) vs nonpneumonic acute exacerbations (NPAE) of COPD. DESIGN: A prospective, observational study. SETTING: A tertiary university medical center in southern Israel. PATIENTS: Twenty-three hospitalizations for PNAE and 217 hospitalizations for NPAE were included in the study. Paired sera were obtained for each of the hospitalizations and were tested serologically for 12 pathogens. Only a significant change in antibody titers or levels was considered diagnostic. RESULTS: No significant differences were found between the two groups for any of the parameters related to COPD or comorbidity. The clinical type of the exacerbation was not significantly different between the groups. Compared to NPAE, patients with PNAE had lower Po(2) values at hospital admission (p = 0.004) but higher rates of abrupt onset (p = 0.005), ICU admissions (p = 0.006), invasive mechanical ventilation (p = 0.01), mortality (p = 0.007), and longer hospital stay (p = 0.001). In 22 PNAE hospitalizations (96%) and in 153 NPAE hospitalizations (71%), at least one infectious etiology was identified (p = 0.001). Mixed infection was found in 13 patients with PNAE (59%) and in 59 patients with NPAE (39%; not significant [NS]). Viral etiology was identified in 18 patients with PNAE (78%) compared with 99 patients with NPAE (46%; p = 0.003). Pneumococcal etiology was found in 10 patients with PNAE (43%) and in 38 patients with NPAE (18%; p = 0.006). An atypical etiology was identified in 8 patients with PNAE (35%) and 64 patients with NPAE (30%; NS). CONCLUSIONS: Community-acquired pneumonia is common among patients hospitalized for an acute exacerbation of COPD and is generally manifested by more severe clinical and laboratory parameters. In PNAE, compared to NPAE, viral and pneumococcal etiologies are more common, but the rate of atypical pathogens is similar. The therapeutic significance of these findings should be investigated further. The American College of Chest Physicians. Published by Elsevier Inc. 2002-10 2015-12-30 /pmc/articles/PMC7094389/ /pubmed/12377851 http://dx.doi.org/10.1378/chest.122.4.1264 Text en © 2002 The American College of Chest Physicians Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lieberman, David
Lieberman, Devora
Gelfer, Yevgenia
Varshavsky, Raiesa
Dvoskin, Bella
Leinonen, Maija
Friedman, Maureen G.
Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
title Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
title_full Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
title_fullStr Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
title_full_unstemmed Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
title_short Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
title_sort pneumonic vs nonpneumonic acute exacerbations of copd
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094389/
https://www.ncbi.nlm.nih.gov/pubmed/12377851
http://dx.doi.org/10.1378/chest.122.4.1264
work_keys_str_mv AT liebermandavid pneumonicvsnonpneumonicacuteexacerbationsofcopd
AT liebermandevora pneumonicvsnonpneumonicacuteexacerbationsofcopd
AT gelferyevgenia pneumonicvsnonpneumonicacuteexacerbationsofcopd
AT varshavskyraiesa pneumonicvsnonpneumonicacuteexacerbationsofcopd
AT dvoskinbella pneumonicvsnonpneumonicacuteexacerbationsofcopd
AT leinonenmaija pneumonicvsnonpneumonicacuteexacerbationsofcopd
AT friedmanmaureeng pneumonicvsnonpneumonicacuteexacerbationsofcopd